Total Payments
$109,834
2024 Payments
$8,411
Companies
35
Transactions
432
Medicare Patients
4,946
Medicare Billing
$360,714
Payment Breakdown by Category
Other$88,248 (80.3%)
Food & Beverage$8,637 (7.9%)
Consulting$7,245 (6.6%)
Travel$5,704 (5.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $88,248 | 45 | 80.3% |
| Food and Beverage | $8,637 | 350 | 7.9% |
| Consulting Fee | $7,245 | 4 | 6.6% |
| Travel and Lodging | $5,704 | 33 | 5.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $83,750 | 124 | $0 (2024) |
| Relypsa, Inc. | $14,350 | 16 | $0 (2018) |
| PFIZER INC. | $5,190 | 35 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $998.08 | 39 | $0 (2024) |
| CVRx, Inc. | $879.79 | 7 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $819.16 | 41 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $648.74 | 34 | $0 (2024) |
| HEARTFLOW, INC. | $391.67 | 4 | $0 (2024) |
| Merck Sharp & Dohme LLC | $287.13 | 16 | $0 (2024) |
| Boston Scientific Corporation | $284.05 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,411 | 55 | Janssen Pharmaceuticals, Inc ($7,212) |
| 2023 | $15,289 | 62 | Janssen Pharmaceuticals, Inc ($13,896) |
| 2022 | $5,715 | 28 | Janssen Pharmaceuticals, Inc ($5,164) |
| 2021 | $5,671 | 20 | Janssen Pharmaceuticals, Inc ($5,450) |
| 2020 | $5,991 | 27 | Janssen Pharmaceuticals, Inc ($5,664) |
| 2019 | $13,535 | 52 | Janssen Pharmaceuticals, Inc ($12,963) |
| 2018 | $17,435 | 72 | Janssen Pharmaceuticals, Inc ($13,329) |
| 2017 | $37,787 | 116 | Janssen Pharmaceuticals, Inc ($20,073) |
All Payment Transactions
432 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/16/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: DIABETES | ||||||
| 12/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Cardiology | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: DIABETES | ||||||
| 11/11/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $27.69 | General |
| Category: Cardiovascular | ||||||
| 10/21/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: DIABETES | ||||||
| 10/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Cardiology | ||||||
| 10/09/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/07/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $162.96 | General |
| Category: Renal Denervation System | ||||||
| 10/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Cardio-renal | ||||||
| 09/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Cardio-renal | ||||||
| 09/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.57 | General |
| Category: Cardiovascular | ||||||
| 09/17/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $34.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/30/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $75.10 | General |
| Category: AVVIGO_IC | ||||||
| 08/28/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $31.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/27/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.11 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,399.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/19/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,215 | 1,685 | $316,667 | $91,476 |
| 2022 | 9 | 1,239 | 1,724 | $256,834 | $87,390 |
| 2021 | 10 | 1,179 | 1,757 | $250,196 | $96,335 |
| 2020 | 13 | 1,313 | 1,783 | $247,608 | $85,512 |
Total Patients
4,946
Total Services
6,949
Medicare Billing
$360,714
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 418 | 694 | $194,778 | $60,491 | 31.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 108 | 122 | $23,864 | $7,287 | 30.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $18,300 | $6,202 | 33.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 436 | 613 | $35,554 | $6,198 | 17.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 97 | 99 | $23,153 | $4,944 | 21.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $12,038 | $3,588 | 29.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 14 | $5,314 | $1,876 | 35.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 41 | 41 | $2,378 | $623.45 | 26.2% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 27 | 28 | $1,288 | $267.36 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 380 | 625 | $144,110 | $55,073 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 155 | 191 | $30,743 | $11,424 | 37.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 49 | 49 | $20,673 | $6,882 | 33.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 470 | 667 | $36,754 | $6,660 | 18.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 99 | 102 | $16,602 | $4,877 | 29.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $4,333 | $1,397 | 32.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 33 | 33 | $1,889 | $537.11 | 28.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 27 | 27 | $1,219 | $277.80 | 22.8% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 13 | 17 | $511.00 | $263.46 | 51.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 374 | 641 | $138,010 | $59,182 | 42.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 59 | 59 | $24,190 | $9,969 | 41.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 463 | 736 | $39,744 | $7,981 | 20.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 99 | 121 | $17,787 | $7,589 | 42.7% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 84 | 85 | $13,260 | $4,639 | 35.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 30 | 34 | $9,792 | $4,221 | 43.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $4,634 | $1,786 | 38.5% |
About Dr. George Kramer, M.D
Dr. George Kramer, M.D is a Interventional Cardiology healthcare provider based in Marietta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720056443.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Kramer, M.D has received a total of $109,834 in payments from pharmaceutical and medical device companies, with $8,411 received in 2024. These payments were reported across 432 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($88,248).
As a Medicare-enrolled provider, Kramer has provided services to 4,946 Medicare beneficiaries, totaling 6,949 services with total Medicare billing of $360,714. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease
- Location Marietta, GA
- Active Since 03/09/2006
- Last Updated 12/02/2019
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1720056443
Products in Payments
- XARELTO (Drug) $83,759
- Veltassa (Drug) $14,350
- ELIQUIS (Drug) $5,885
- Barostim Neo System (Device) $879.79
- ENTRESTO (Drug) $656.42
- FFRct (Device) $391.67
- JARDIANCE (Drug) $376.57
- VERQUVO (Drug) $287.13
- PRADAXA (Drug) $272.17
- NEXLETOL (Drug) $266.11
- BRILINTA (Drug) $203.57
- Repatha (Biological) $184.61
- SYMPLICITY G3 (Device) $162.96
- LEQVIO (Drug) $162.74
- LifeVest (Device) $162.07
- CHANTIX (Drug) $139.38
- Vascepa (Drug) $131.59
- PRALUENT (Drug) $102.30
- Corlanor (Drug) $92.21
- VYNDAQEL (Drug) $91.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Marietta
Dhaval Patel, M.d, M.D
Interventional Cardiology — Payments: $72,112
Interventional Cardiology $72,112
John Goddard, M.d, M.D
Interventional Cardiology — Payments: $9,236
Interventional Cardiology $9,236
Dr. Amol Bapat, M.d, M.D
Interventional Cardiology — Payments: $5,920
Interventional Cardiology $5,920
Nabil Sabbak, Md, MD
Interventional Cardiology — Payments: $5,272
Interventional Cardiology $5,272
Cheryl Robertson, M.d, M.D
Interventional Cardiology — Payments: $3,707
Interventional Cardiology $3,707
Jagdesh Kandala, Md, MD
Interventional Cardiology — Payments: $1,574
Interventional Cardiology $1,574